Shareholders’ Equity (Details Narrative) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Aug. 01, 2025 |
Jul. 30, 2025 |
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
| Proceeds from issues of common stock | $ 5,749,400 | |||
| Offering expenses | 4,940,690 | |||
| Legal fees | $ 75,000 | |||
| Stock Issued During Period, Shares, Restricted Stock Award, Forfeited | 250,905 | |||
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price | $ 1.15 | |||
| Treasury Stock, Common, Shares | 12,253,502 | 12,253,502 | ||
| Treasury Stock, Value | $ 18,929,915 | $ 18,929,915 | ||
| IPO [Member] | Chief Operating Officer [Member] | ||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
| Number of shares issued | 26,000 | |||
| Common Stock [Member] | ||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
| Sale of shares issued | 6,052,000 | |||
| Stock price per share | $ 0.95 | $ 0.95 | ||
| Number of shares issued | 6,052,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for cost associated with issuance of security by investment company. Includes, but is not limited to, legal fee pertaining to share offered for sale, registration fee, underwriting, printing prospectus, and initial fee for listing on exchange. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could acquire or could have acquired the underlying shares with respect to any other type of change in shares reserved for issuance. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares related to Restricted Stock Award forfeited during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|